Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Dermatology Nursing|August 1, 1995
Zingiber officinale (ginger) used to prevent 8-Mop associated nauseaK Meyer, J Schwartz, D Crater, et al.Electrophoresis|May 1, 1989
Mobility surfaces for field-inversion gel electrophoresis of linear DNAG D Crater, M R Gregg, G HolzwarthTherapeutic Advances in Respiratory Disease|March 2, 2022
Lung deposition of inhaled once-daily long-acting muscarinic antagonists <i>via</i> standard jet nebulizer or dry powder inhaler, measured using functional respiratory imaging, in patients with chronic obstructive pulmonary diseaseGlenn D Crater, Karmon Johnson, Jonathan Ward, et al.Respiratory Medicine|March 20, 2012
Rehospitalization risks and outcomes in COPD patients receiving maintenance pharmacotherapyAnand A Dalal, Manan Shah, Anna O D'Souza, et al.The Open Respiratory Medicine Journal|January 22, 2011
Safety and efficacy of fluticasone propionate/salmeterol hydrofluoroalkane 134a metered-dose-inhaler compared with fluticasone propionate/salmeterol diskus in patients with chronic obstructive pulmonary diseaseAndras Koser, Jan Westerman, Sanjay Sharma, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 24, 2020
Safety and Efficacy of Revefenacin and Formoterol in Sequence and Combination via a Standard Jet Nebulizer in Patients with Chronic Obstructive Pulmonary Disease: A Phase 3b, Randomized, 42-Day StudyThomas M Siler, Edmund J Moran, Chris N Barnes, et al.Dermatology Nursing|February 1, 1993
Photopheresis for ARC: a nursing perspectiveC Cahill, B Keyes, D Crater, et al.Diabetes, Obesity & Metabolism|November 9, 2023
Effects of CB1R inverse agonist, INV-202, in patients with features of metabolic syndrome. A randomized, placebo-controlled, double-blind phase 1b studyGlenn D Crater, Karine Lalonde, François Ravenelle, et al.Therapeutic Advances in Respiratory Disease|February 29, 2020
Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trialsSanjay Sethi, James F Donohue, Gary T Ferguson, et al.Biopolymers|June 1, 1989
The acceleration of linear DNA during pulsed-field gel electrophoresisG Holzwarth, K J Platt, C B McKee, et al.Pageof 3